Dear Editor, Multiple Sclerosis (MS) is a chronic infammatory disease of the central nervous system (CNS) representing a relevant cause of disability in young adults. In the last 20 years, new and emerging disease-modifying drugs (DMD) have been introduced in clinical practice revolutionizing the natural history of the disease [1]. However, immunomodulatory and immunosuppressive treatments for MS are associated with an increased risk of severe infections, which ranges from 0.2% to 2.6% [2]
Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate
Bollo, Luca;Caputo, Francesca;Paolicelli, Damiano;Trojano, Maria;Iaffaldano, Pietro
2022-01-01
Abstract
Dear Editor, Multiple Sclerosis (MS) is a chronic infammatory disease of the central nervous system (CNS) representing a relevant cause of disability in young adults. In the last 20 years, new and emerging disease-modifying drugs (DMD) have been introduced in clinical practice revolutionizing the natural history of the disease [1]. However, immunomodulatory and immunosuppressive treatments for MS are associated with an increased risk of severe infections, which ranges from 0.2% to 2.6% [2]File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
